drugset
Drugs / Medical Oxygen
last change Aug 2022 re-read 3 minutes ago

Medical Oxygen

Developed for
ischemic stroke · lymphedema
Investigated by
CORE BIOMARKER LABORATORY: Fundatio Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain · CORE IMAGING LABORATORY: Eppdata GmbH, 22529 Hamburg, Germany · Centre Hospitalier Universitaire, Amiens · Danish Cancer Society · European Clinical Research Infrastructure Network (ECRIN), 10559 Berlin, Germany · Heinrich-Heine University, Duesseldorf
+3 more · Herlev Hospital · Rigshospitalet, Denmark · University Hospital Tuebingen

Trials 3

today NCT03500939 · Ph 2 NCT02895724 · Ph 2 NCT02819739 · Ph 3
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT03500939 Aug 2019 → May 2022 ischemic stroke University Hospital Tuebingen Terminated No outcome recorded
Phase 2 NCT02895724 Sep 2016 → Dec 2018 lymphedema Danish Cancer Society Unknown No outcome recorded
Phase 31 trial · 1 missed
Phase 3 NCT02819739 Nov 2014 → Oct 2018 — Centre Hospitalier Universitaire, Amiens Completed Missed primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Medical Oxygen ClinicalTrials.gov intervention name — accepted as the source's own label NCT02895724 ↗
2

NCT02819739 ↗

NCT03500939 ↗
Route Inhaled “Patients breathe 100% oxygen via a transparent hood” NCT02895724 ↗